Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
Utachee P, Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M. Utachee P, et al. Among authors: kameoka m. J Virol. 2010 May;84(9):4311-20. doi: 10.1128/JVI.02619-09. Epub 2010 Feb 17. J Virol. 2010. PMID: 20164234 Free PMC article.
The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors.
Kameoka M, Isarangkura-na-Ayuthaya P, Kameoka Y, Sapsutthipas S, Soonthornsata B, Nakamura S, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W. Kameoka M, et al. Among authors: kameoka y. Virology. 2010 Sep 15;405(1):129-38. doi: 10.1016/j.virol.2010.06.003. Epub 2010 Jun 22. Virology. 2010. PMID: 20573365 Free article.
Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.
Utachee P, Isarangkura-na-ayuthaya P, Tokunaga K, Ikuta K, Takeda N, Kameoka M. Utachee P, et al. Among authors: kameoka m. Retrovirology. 2014 Apr 23;11:32. doi: 10.1186/1742-4690-11-32. Retrovirology. 2014. PMID: 24758333 Free PMC article.
160 results